Pooling biospecimens within individuals, a solution to highly variable expensive biomarkers: practical or idealistic?

ABSTRACT Background: Existing methodology to analyze pooled biospecimens, a cost-effective way for measuring expensive biomarkers, consider study designs where biospecimens are pooled across individuals, but not within individuals. Pooling biospecimens across individuals is not effective when the target biomarker is highly variable. Furthermore, ignoring the variability leads to grossly biased effect estimates (s). Repeated samples within subject are recommended but not always practical. A novel study design is needed to bridge this limitation. Methods: We propose a study design where the target biomarker is measured from pooled biospecimens collected over time from every study participant and derived a bias-correction factor corresponding to this pooling strategy. We simulated 1000 different samples of size 1088 with different pooling strategies and 3 different scenarios of biomarker variability, namely 1) pooling error > measurement error, 2) pooling error < measurement error, and 3) pooling error = measurement error. With this simulation study we assessed the robustness of our proposed design by comparing the Mean Absolute Error (MAE) and Root Mean Square Error (RMSE) for uncorrected and bias-corrected s for a binary outcome. Results: The MAE and RMSE for bias-corrected s were lower compared to uncorrected s, across all scenarios of biomarker variability. The MAE and RMSE are minimum when pooling error < measurement error. Conclusion: Combined with an appropriate regression calibration method, pooling biospecimens within individuals is a statistically robust and cost-effective solution to measuring highly variable expensive biomarkers.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-09-16
DOI
https://doi.org/10.5281/zenodo.17479234
Primary Topic
Statistical Methods in Clinical Trials
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pooling biospecimens within individuals, a solution to highly variable expensive biomarkers: practical or idealistic?

Zenodo (CERN European Organization for Nuclear Research)
Statistical Methods in Clinical Trials
article

Pooling biospecimens within individuals, a solution to highly variable expensive biomarkers: practical or idealistic?

article en

Abstract

ABSTRACT Background: Existing methodology to analyze pooled biospecimens, a cost-effective way for measuring expensive biomarkers, consider study designs where biospecimens are pooled across individuals, but not within individuals. Pooling biospecimens across individuals is not effective when the target biomarker is highly variable. Furthermore, ignoring the variability leads to grossly biased effect estimates (s). Repeated samples within subject are recommended but not always practical. A novel study design is needed to bridge this limitation. Methods: We propose a study design where the target biomarker is measured from pooled biospecimens collected over time from every study participant and derived a bias-correction factor corresponding to this pooling strategy. We simulated 1000 different samples of size 1088 with different pooling strategies and 3 different scenarios of biomarker variability, namely 1) pooling error > measurement error, 2) pooling error < measurement error, and 3) pooling error = measurement error. With this simulation study we assessed the robustness of our proposed design by comparing the Mean Absolute Error (MAE) and Root Mean Square Error (RMSE) for uncorrected and bias-corrected s for a binary outcome. Results: The MAE and RMSE for bias-corrected s were lower compared to uncorrected s, across all scenarios of biomarker variability. The MAE and RMSE are minimum when pooling error < measurement error. Conclusion: Combined with an appropriate regression calibration method, pooling biospecimens within individuals is a statistically robust and cost-effective solution to measuring highly variable expensive biomarkers.

Zenodo (CERN European Organization for Nuclear Research)
California University of Pennsylvania (US), University of Pennsylvania (US)
Openalex Percentile: Top 36%
Statistical Methods in Clinical Trials
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pooling biospecimens within individuals, a solution to highly variable expensive biomarkers: practical or idealistic? · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS